Completed PHASE4 INTERVENTIONAL 2-arm NCT04319614

Can the Prophylactic Administration of Tranexamic Acid Reduce Blood Loss After Robotic-assisted Radical Prostatectomy? (RARPEX)

Can the Prophylactic Administration of Tranexamic Acid Reduce Blood Loss After Robotic-assisted Radical Prostatectomy? The RARPEX (Robotic Assisted Radical Prostatectomy With TranEXamic Acid) Study.

Sponsor: University Hospital Hradec Kralove

Conditions Robotic-assisted Radical Prostatectomy

Interventions Placebos Tranexamic Acid Injectable Product

Updated 6 times since 2020 Last updated: Nov 6, 2022 Started: Feb 24, 2020 Primary completion: Feb 12, 2022 Completion: Jun 30, 2022

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE4 clinical study on Robotic-assisted Radical Prostatectomy, this trial is completed. The trial is conducted by University Hospital Hradec Kralove and has accumulated 6 data snapshots since 2020. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Dec 2022 — Jul 2024 [monthly]

Completed PHASE4

Status: Recruiting → Completed
Nov 2021 — Dec 2022 [monthly]

Recruiting PHASE4
Jan 2021 — Nov 2021 [monthly]

Recruiting PHASE4

▶ Show 1 earlier version

Apr 2020 — Jan 2021 [monthly]

Recruiting PHASE4

First recorded

Feb 2020

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University Hospital Hradec Kralove

Data source: University Hospital Hradec Kralove

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Hradec Králové, Czechia